Cardiac Guidance vs QFR
AI Verdict
Choose Cardiac Guidance if…
Choose Cardiac Guidance if your primary need is to empower healthcare professionals, including those without extensive sonography experience, to acquire diagnostic-quality cardiac ultrasound images and perform basic assessments at the point of care. This tool is ideal for expanding access to early cardiac disease detection and monitoring in settings where rapid, guided image acquisition and automated quality control are crucial.
View Cardiac Guidance →Choose QFR if…
Choose QFR if your focus is on performing advanced, quantitative analysis of coronary artery lesions from existing X-ray angiographic images to determine their functional significance. This solution is specifically designed for cardiologists within a cath lab environment, providing detailed anatomical quantification and quantitative flow ratio (QFR) assessment to inform interventional treatment decisions.
View QFR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | QFR |
|---|---|---|
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | On-premise (integrates into cath lab environment) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceCardiac Guidance (Tool A) is specifically designed to enable non-expert ultrasound users, such as nurses, to acquire diagnostic-quality cardiac images through real-time AI guidance and on-screen instructions. This focus on simplifying a complex procedure for a broader audience demonstrates superior usability. QFR (Tool B) enhances expert analysis but does not aim to simplify image acquisition for non-specialists.
Clinical Value
Cardiac GuidanceCardiac Guidance (Tool A) significantly expands access to critical cardiac assessments by enabling non-experts to perform diagnostic-quality echocardiograms at the point of care, addressing workforce shortages and potentially leading to earlier disease detection. Clinical studies have validated its effectiveness in acquiring images for key cardiac assessments. While QFR (Tool B) provides valuable functional assessment for cardiologists, its impact on democratizing access to diagnostics is less pronounced, and some studies have noted variability in its real-world performance.
Pricing & Value
Cardiac GuidanceBoth tools require contacting the vendor for pricing. However, Cardiac Guidance (Tool A) has secured CMS New Technology Add-on Payment (NTAP) status, which provides a clear reimbursement pathway for hospitals and reduces financial barriers to adoption. This established mechanism for financial value is not evident for QFR (Tool B).
Enterprise Readiness
Cardiac GuidanceCardiac Guidance (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), and it integrates with compatible general-purpose diagnostic ultrasound systems. Its acquisition by GE HealthCare further strengthens its enterprise support and scalability. QFR (Tool B)'s HIPAA compliance is listed as 'unknown' in the provided facts, and its on-premise deployment might present more IT overhead.
Innovation
Cardiac GuidanceCardiac Guidance (Tool A) represents a more disruptive innovation by being the first FDA-cleared AI software to guide non-expert users in acquiring diagnostic-quality cardiac ultrasound images, fundamentally changing how this critical diagnostic procedure can be performed and accessed. This 'democratization' of a complex skill has a broader impact on healthcare delivery. QFR (Tool B) offers significant innovation in non-invasive functional assessment of coronary lesions, but it enhances an existing expert workflow rather than enabling new user groups.
Support & Docs
Cardiac GuidanceInformation for Cardiac Guidance (Tool A) indicates that an electronic Operator's Manual is accessible directly from the software interface and within the associated app, suggesting readily available and integrated documentation. For QFR (Tool B), no specific information regarding support or documentation was found in the provided data or web searches related to the medical device.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | QFR |
|---|---|---|
| Name | Cardiac Guidance | QFR |
| Company | Caption Health | QFR Solutions bv |
| Description | FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments. | FDA-cleared AI-powered medical software for the visualization and quantitative flow ratio (QFR) analysis of X-ray angiographic images of coronary vessel segments, aiding cardiologists in lesion assessment. |
| Primary Modality | Cardiac Ultrasound | X-ray Angiography |
| Key Feature 1 | Real-time AI guidance for cardiac ultrasound image acquisition | Visualization of X-ray angiographic images |
| Key Feature 2 | Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation) | Quantitative Flow Ratio (QFR) assessment for functional significance |
| Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and QFR.